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Arsenic contamination of drinking water affects more than 140 million people worldwide. While toxic to 
humans, inorganic forms of arsenic (arsenite and arsenate), can be used as energy sources for microbial 
respiration. AioX and its orthologues (ArxX and ArrX) represent the first members of a new sub-family 
of periplasmic-binding proteins that serve as the first component of a signal transduction system, 
that’s role is to positively regulate expression of arsenic metabolism enzymes. As determined by X-ray 
crystallography for AioX, arsenite binding only requires subtle conformational changes in protein 
structure, providing insights into protein-ligand interactions. The binding pocket of all orthologues 
is conserved but this alone is not sufficient for oxyanion selectivity, with proteins selectively binding 
either arsenite or arsenate. Phylogenetic evidence, clearly demonstrates that the regulatory proteins 
evolved together early in prokaryotic evolution and had a separate origin from the metabolic enzymes 
whose expression they regulate.
Arsenic, although toxic to most living organisms, can be used for respiration by some prokaryotes. Under anoxic 
conditions, arsenate (+V) can serve as a terminal electron acceptor coupling its reduction to the oxidation of a 
variety of organic and inorganic electron donors1. With oxygen or nitrate (at pH > 9) as the terminal electron 
acceptor, arsenite (+III) can be used as an electron donor with some organisms clearly gaining energy from 
its oxidation2,3. In all cases of arsenic metabolism, the metabolic enzymes involved in the oxidation or reduc-
tion reactions are members of the DMSO reductase family of molybdenum-containing enzymes4–8. The most 
well characterised arsenic-metabolising enzyme is the arsenite oxidase (Aio) purified from aerobic arsenite 
oxidisers, with two X-ray crystal structures resolved9,10. Aio consists of two heterologous subunits, a catalytic 
molybdopterin guanine dinucleotide-containing subunit (AioA) that also contains a 3Fe-4S cluster, and a small 
Rieske subunit (AioB)9. The respiratory arsenate reductase (Arr) has been purified and characterised from three 
organisms6,8,11 and like the Aio consists of two heterologous subunits, a molybdenum-containing subunit (ArrA), 
which based on sequence analysis contains one 4Fe-4S cluster and a small subunit (ArrB) with four 4Fe-4S clus-
ters8. The alternative arsenite oxidase, Arx, which operates in an anaerobic respiratory chain with nitrate reduc-
tase as the terminal reductase, has not been studied biochemically but is thought to consist of four subunits based 
on the arx loci (Fig. 1). Two of the gene products (ArxA and ArxB) have a high degree of sequence similarity to 
ArrA/B suggesting an identical cofactor composition; in Arx there is also another putative subunit that contains 
six predicted 4Fe-4S clusters (ArxB′) and an integral membrane protein (ArxC)5,12,13.
In some arsenic-metabolising bacteria, expression of the molybdoenzyme is strictly regulated, with gene 
expression only detected when the organism is grown in the presence of the arsenic oxyanion2,6,12,14–16. The expres-
sion of Aio in the Proteobacteria is regulated by a regulatory gene cluster adjacent to the arsenite oxidase genes 
(aioBA). The regulatory cluster consists of three genes, aioX, aioS and aioR, which encode a periplasmic-binding 
protein (PBP), a sensor histidine kinase and a response regulator, respectively. All three genes are essential for 
arsenite oxidase gene (aioBA) expression14,16–19 and in the case of Rhizobium sp. str. NT-26 are co-transcribed20. 
AioX is thought to be the sensing protein as it has been shown to bind arsenite in vitro14. Arsenite-bound AioX is 
thought to act as a ligand for AioS, the sensor histidine kinase that upon auto-phosphorylation, phosphorylates 
AioR, the response regulator, which binds to a conserved sequence upstream of a RpoN promoter14,15,18,19.
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Here we report the identification and characterisation of a new subfamily of arsenic oxyanion-binding pro-
teins from phylogenetically distant bacteria that have evolved to regulate bioenergetic arsenic metabolism. These 
proteins, which demonstrate substrate selectivity, could be used as novel sensors for both toxic arsenic oxyanions.
Results
Conservation of the XSR regulatory gene cluster. The aioXSR regulatory gene cluster is found in some 
arsenite oxidisers of the Alpha- and Betaproteobacteria. Searches of the GenBank database, revealed that the XSR 
regulatory module was conserved in a sub-set of other phylogenetically distant arsenic-metabolising bacteria 
including the anaerobic arsenite oxidiser, Alkalilimnicola ehrlichii str. MLHE-1 (Gammaproteobacteria) (encode 
Arx – genes are arxB′ABC) and the arsenate respirer, Chrysiogenes arsenatis (Chrysiogenetes) (encode Arr – genes 
are arrAB) (Fig. 1). This finding suggests that the XSR proteins in these organisms regulate expression of the 
respective molybdenum-containing enzyme.
AioR and ArxR are the response regulators controlling expression of the arsenite oxidase genes and are mem-
bers of the AtoC family of response-regulators (similar structure to the response regulator for acetoacetate sens-
ing in Escherichia coli21), which contain a AAA+ ATPase domain. Like in NT-26, a putative RpoN promoter 
(tggcaaggctattgct) and ArxR-binding site (gtaacaattcaagc) (based on homology to the NT-26 AioR-binding 
site), were identified upstream of the arsenite oxidase genes. ArrR, is a member of a different response regulator 
family, namely the CitB-like family, similar to the response regulator for citrate sensing in Klebsiella pneumo-
niae22 and unlike AioR/ArxR does not possess an AAA+ ATPase domain. ArrR has sequence similarity to the 
DNA-binding, helix-turn-helix portion of FixJ23, with a putative FixJ-like binding site motif24 (tcaggtttttccctga) 
identified upstream of arrA.
Regulatory modules and molybdenum-containing subunits have different phylogenies. The 
phylogeny of the XSR regulatory modules are congruent with the 16S rRNA gene phylogeny (Fig. 2; annotated 
16S rRNA tree as Fig. S2). By contrast, in the tree for the molybdenum-containing subunit of the metabolic 
enzymes, Aio forms a separate clade from Arx and Arr (Fig. 2). The trend is exemplified by the Arx regulatory 
proteins from the Alphaproteobacterium Magnetospirillum magnetotacticum, where the 16S rRNA gene, ArxX, 
ArxS and ArxR sequences all cluster with other Alphaproteobacteria, which are all aerobic arsenite oxidisers 
(Fig. 2). The ArrR from the Epsilonproteobacteria are more similar (i.e. they are in the AtoC family) to ArxR and 
AioR than to the ArrR from the Firmicutes and Chysiogenetes, which is a further example of how the XSR phylog-
eny is more congruent to the 16S rRNA gene than to that of the molybdenum-containing enzyme.
Figure 1. Gene arrangements for the arsenite oxidase (aio), alternative arsenite oxidase (arx) and respiratory 
arsenate reductase (arr) gene clusters. The aio represented is from Rhizobium sp. str. NT-26, arx from 
Alkalilimnicola ehrlichii str. MLHE-1 and arr from Chrysiogenes arsenatis. A: molybdenum-containing subunit; 
B: iron-sulphur protein; C: integral membrane subunit; R: response regulator; S: sensor histidine kinase; X: 
oxyanion-binding subunit. Putative promoter sites for RpoN are indicated, we could not detect a promoter 
upstream of arrAB.
Figure 2. Phylogeny of arsenic-metabolising bacteria, metabolic enzymes and regulatory proteins. Trees 
are for 16S rRNA gene (16S); AioX homologues (X); AioS homologues (S); AioR homologues (R); and the 
molybdenum-containing subunits of Aio, Arx and Arr (Mo). Trees are bootstrap consensus trees constructed 
using the maximum-likelihood method from 200 resamples and are rooted using the 16S rRNA gene from 
Sulfolobus tokodaii, and the protein sequences from TorT, TorS, TorR and TorA for X, S, R and Mo, respectively.
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The genes that encode the alternative arsenite oxidase (arxB’ABC) together with the regulatory clus-
ter (arxXSR) are conserved in anaerobic arsenite oxidisers, all of which are members of the Alpha-, Beta- and 
Gammaproteobacteria. The aioBA genes are more widespread, with homologues in both prokaryotic domains of 
life and in the following phyla of the Bacteria, Proteobacteria, Chloroflexi and Thermus-Deinococcus. The aioXSR 
regulatory module, however, is present only in some arsenite oxidisers in the Alpha- and Betaproteobacteria. In 
the arsenate respirers, the arrAB genes are present in members of the Firmicutes, Proteobacteria (Gamma- and 
Epsilonproteobacteria), Chrysiogenetes and Deferribacteres phyla while the arrXSR genes are present in all of these 
except the Gammaproteobacteria and the Deferribacteres.
Phylogeny and evolutionary history of AioX. Based on sequence comparisons, AioX appears to rep-
resent a new subfamily of the PBPs25 where the majority of the proteins bind tetrahedral oxyanions, including 
phosphate, sulphate, molybdate and tungstate26 (Fig. 3). The new subfamily is distinct from the other proteins as 
it functions in sensing and not oxyanion transport26–28. As expected, the closest homologues include ArxX and 
ArrX presumed to be involved in sensing arsenite and arsenate, respectively.
Three-dimensional structure of AioX. Structures of the apo, arsenite-bound and phosphate-bound forms 
of AioX were solved and deposited in PDB with the following IDs: 6ESK, 6EU7 and 6ESV, respectively. X-ray 
data and refinement statistics are presented in Table 1. AioX exhibits a typical bilobed structure of the PBP type II 
class25. The 304 amino acid residue polypeptide folds into two similar α/β domains. Each domain contains mixed 
beta-sheets, one with 6 strands and the other with 5; one strand is antiparallel to the rest in each domain (Fig. 4). 
The two domains are linked by two crossing-over protein strands, such that one links the beta strand 4 of the 
first domain to the beta strand 1 of the second domain, while the second crossover links the beta strand 5 of the 
second domain back to the beta strand 5 of the first domain. In addition, there is a C-terminal extension to the 
canonical fold, which is the sixth beta strand in the first domain and a C-terminal helix.
The AioX topology closely resembles that of the E. coli phosphonate-binding protein PhnD (Fig. 4). The 
NT-26 AioX and the E. coli PhnD proteins share 20% sequence identity over 245 aligned residues while the two 
structures superpose with a core rmsd of 1.84 Å, indicating close structural homology. In this class of proteins, the 
ligand-binding pocket is located in the space between the two domains.
In the initial single-wavelength anomalous diffraction (SAD) electron density maps generated from the crys-
tals of Se-Met labelled protein there was an unaccounted electron density in the putative ligand-binding region 
near residue Cys106. The electron density was consistent with the presence of a phosphate ion, from the crystalli-
sation conditions, and its location would suggest that Cys106 might be involved in binding arsenite.
Arsenite-bound AioX displays significant conformational changes. The crystal structure of the 
phosphate-bound AioX was used to solve the structures of the apo and arsenite-bound forms of the protein by 
molecular replacement. Figure 5 shows the AioX ligand-binding site with arsenite forming a link to the sulphur 
atom of Cys106, confirming the role of this residue in arsenite binding. Figure 5 also shows an overlay of the apo 
Figure 3. Maximum-likelihood phylogenetic tree of AioX and its homologues. ABP, antigen-binding protein; 
AioX (red) and ArxX (blue), arsenite-binding proteins; ArrX, (green), arsenate-binding proteins; MBP, 
molybdate-binding proteins (a: archaeal; b: bacterial); PBP, phosphate-binding proteins (*involved in sensing 
not transport); PhnD, phosphonate-binding proteins; SBP: sulphate-binding proteins; TBP: tungstate-binding 
protein.
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and the arsenite-bound forms of AioX accentuating the most pronounced differences between the two structures. 
While the majority of both structures overlay very well, there is a significant difference in the rotamer confor-
mation of Tyr88. The change in the side chain conformation is further associated with the backbone shift for 
residues 83–88 and a significant conformational change in the loop region comprising residues 53–61, demarked 
by the black circle in Fig. 5A. This conformational change upon arsenite binding involves a hydrophobic collapse 
Protein (AioX) Apo Arsenite-bound Phosphate-bound
PDB ID 6ESK 6EU7 6ESV
Data collection
Space Group P 43 21 2 C 2 P 43 21 2
Cell dimensions
a, b, c (Å) 124.88, 124.88, 47.73 202.36, 116.92, 136.84 124.5, 124.5, 48.01
α, β, γ (°) 90.0, 90.0, 90.0 90.0, 90.02, 90.0 90.0, 90.0, 90.0
Resolution (Å) 44.59–1.75 (1.78–1.75)a 44.44–3.00 (3.07–3.00) 44.03–1.78 (1.82–1.78)
Rmerge 0.380 (12.334)b 0.11 (0.587) 0.109 (2.036)
Completeness (%) 98.9 (81.0) 97.9 (99.0) 99.8 (100)
Multiplicity 12.8 (9.1) 4.0 (4.1) 16.4 (16.6)
CC1/2 0.996 (0.126)b 0.993 (0.651) 0.998 (0.740)
Mean((I)/sd(I)) 7.6 (0.4)b 10.0 (2.5) 19.3 (2.1)
Refinement
Total number of observations 492945 249664 603454
Total number unique 38474 62521 36718
Rwork/free 0.19/0.21 0.19/0.21 0.19/0.22
RMS deviations
Bonds (Å) 0.022 0.014 0.021
Angles (°) 1.969 1.659 2.008
Mean B-factors (Å2) 29.7 61.3 31.7
Ramachandran plot (%)
Favoured 98.1 95.4 97.3
Allowed 1.5 4.4 2.7
Outliers 0.4 0.3 0
Table 1. Data collection and refinement statistics. aData for the highest resolution shell is shown in parenthesis. 
bEffective resolution of this data set based on CC1/2 and Mean((I)/sd(I)) is1.85 Å and 1.97 Å, respectively. Rmerege 
at 1.97 Å is 0.267. All data was used in the refinement.
Figure 4. Structure of AioX superimposed with that of PhnD. The bilobal structure of AioX is shown in 
ribbon representation (yellow) and compared to that of the E. coli protein PhnD in complex with its ligand 
2-aminoethyl phosphonate (blue ribbons and blue sticks, respectively). The AioX structure shown is that of the 
SAD method solved structure, which contains phosphate in its binding pocket. Two conserved tyrosine residues 
(Y88 and Y131), AioX-specific residue C106, and a phosphate ion are shown as sticks and coloured based on the 
type of the atom (phosphorous-orange, oxygen-red, nitrogen-blue, and carbon-grey).
www.nature.com/scientificreports/
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of the loop, with residues Val56, Phe57 and Leu58 reaching towards the core of the protein and closing of the 
ligand-binding site. Importantly, the conformation of Tyr88, seen in the apo form of AioX and the conformation 
of the 53–61 loop, observed in the arsenite-bound AioX, are mutually exclusive, as the conformations of these two 
parts of the structure would have caused a steric clash.
Furthermore, conformational rearrangement upon arsenite binding would inevitably result in changes to 
the molecular surface of AioX, including its electrostatic potential (Fig. 6). Interestingly, while the structures 
of apo-AioX and the phosphate-bound AioX contained a monomer in the asymmetric unit, the arsenite-bound 
molecule crystallised with six molecules in the asymmetric unit of the unit cell. Although the six molecules 
were arranged as the three repeats of a loosely associated dimer none of the interfaces is sufficiently large to 
be indicative of a biologically significant assembly. It should be noted that while surface residues 59–61 in the 
arsenite-bound structure are near the neighbouring molecule in the asymmetric unit, they are too distant to be 
directly involved in the interactions, while in the apo-AioX Asp61 interacts with the side chain of Arg281 from 
the crystallographic symmetry related molecule. These small differences in molecular packing support the idea 
that 53–61 loop conformation change might result in the generation of a new protein interaction surface.
Phosphate-bound and arsenite-bound forms of AioX are not identical. Superposition of the 
phosphonate-bound structure of PhnD and the phosphate-bound structure of AioX emphasizes the structural 
similarity between the two proteins, while close inspection of the ligand-binding sites identifies a set of conserved 
residues that are engaged in interactions with two similar ligands (Figs 4 and 5A). However, the two binding sites 
are not identical and while one side of the binding pocket contains identical residues, Ser161, Ser163, His192, 
Tyr88 and Tyr131 specifically (AioX numbering), the other residues in the binding pocket appear to provide 
substrate specificity. In PhnD, the phosphonate molecule forms an additional hydrogen bond with the side chain 
of Thr128 (Asn162 in AioX) and a water-mediated interaction with Ser68, while the carboxylate groups of Glu177 
and Asp205 interact with the positively charged end of the 2-aminoethyl phosphonate (Tyr212 and Pro240 are 
present in the corresponding locations in AioX). On the other hand, a phosphate ion found in the binding site 
of AioX formed AioX-specific hydrogen bonds with Asp210 and Cys106, which in PhnD correspond to Asn175 
and Gly65, respectively.
The presence of a phosphate ion in the binding site of AioX leads to the hypothesis that the phosphate ion 
mimics arsenite binding. A comparison of the X-ray structures however, indicates that while AioX can bind 
Figure 5. Conformational changes associated with arsenite-binding. The structures of the apo (grey), arsenite-
bound (purple) and phosphate-bound (yellow) forms of AioX were overlaid. (A) Arsenite-binding causes the 
Y88 side chain rotamer to change in concert with a large backbone conformational change spanning residues 
53–61 (circled in the Figure). The electron density for the corresponding region in the phosphate-bound AioX 
crystal structure was disordered. (B) Electron density map showing the linkage between the bound arsenite 
and Cys106. (C) Stereo diagram showing a closer view of the loop conformational change with the three 
hydrophobic residues closing in on the ligand-binding site. The figure was created without the smoothing 
function for the backbone representation emphasizing the full extent of the backbone conformational changes 
associated with arsenite binding.
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phosphate, the resulting structure does not stabilize the 53–61 loop conformation seen in the arsenite-bound 
form. Furthermore, even though the structure is similar to the arsenite-bound form, with the main conformation 
of Tyr88 akin to that of the arsenite-AioX (Fig. 7), electron density for residues 53–61 are ambiguous and due to 
the disorder, we were unable to confidently build a model for residues 55–57. Within region 55–57 the structure 
had more similarity to the apo rather than the arsenite-bound form of AioX.
Conservation of AioX-binding pocket in close homologues. The residues that constitute the binding 
pocket of the arsenite- and phosphate-bound structures of AioX, are Tyr88, Cys106, Tyr131, Ser161, Ser163, 
His192 and Asp210. Alignment of AioX with ArrX, ArxX and PhnD sequences (Fig. 8), shows that residues are 
conserved in the AioX subfamily of PBPs, indicating similar substrate-binding capabilities. The alignment also 
highlights the absence of Cys106 in PhnD. The hydrophobic residues which reach towards the core of the protein 
in arsenite-bound AioX are also present in Arx except Phe57 is an Ile (also hydropobic) in Arx (Fig. 8). However, 
the corresponding loop regions in ArrX and PhnD are shorter and more polar with AioX-like residues Val56 and 
Phe57 missing from that part of the sequence (Fig. 8).
Oxyanion-binding studies demonstrate substrate specificity. Although the residues involved in 
binding arsenite and phosphate are conserved in the three orthologues, AioX, ArxX and ArrX (Fig. 8), isother-
mal titration calorimetry (ITC) experiments indicated distinct substrate specificity of these proteins (Fig. 9). 
We tested a range of oxyanions including antimonite, arsenate, arsenite, molybdate, phosphate, phosphonate, 
selenate, sulphate, tetrathionate and thiosulphate as potential ligands for each protein. AioX and ArxX bound 
arsenite with a Kd of 177 and 311 nM, respectively (Fig. 9) and no interaction was detected with any of the other 
substrates tested (data not shown). It was surprising not to detect phosphate binding to AioX or ArxX given, 
(1) we solved a structure of AioX with a phosphate ion in the binding pocket (Fig. 4) and (2) that amino acids 
involved in phosphate binding in the structure of AioX are conserved in ArxX. As we were unable to detect any 
binding interaction, based on the conditions used in the ITC we estimate that the Kd for phosphate would have 
to be greater than 2 mM (data not shown). ArrX bound arsenate and also phosphate with a Kd of 1 and 150 μM, 
respectively (Fig. 9) while no interaction was detected with any of the other ligands tested (data not shown). 
Binding of phosphate to ArrX is not surprising given that arsenate and phosphate have analogous chemical 
structures. Interestingly, ligand-binding affinities for this protein are in micromolar compared to the nanomolar 
range observed for AioX and ArxX indicating complex tuning of the ion-binding mechanisms, probably involv-
ing other structural features beyond direct interactions with the protein side-chains. We used a one-site bind-
ing model to fit the data for ArrX with arsenate, as its homology with AioX indicates a single binding pocket, 
even though the data exhibits a more complex behaviour. A two-site model does fit the data, however the Kd 
values are not replicable between titrations. At pH 8 used in the ITC experiments, the arsenate acquires two 
forms, H2AsO4− and HAsO42−, which could account for different Kd values in the same titration. Alternatively, 
the arsenate titration thermogram might include a component resulting from the ligand-induced protein-protein 
Figure 6. Molecular surface of AioX changes upon arsenite-binding. Molecular surface of AioX, coloured 
based on the electrostatic potential, is shown for the AioX molecule in absence (left) and in the presence (right) 
of arsenite. Top view displays the surface changes contributed by the residues comprising 53–61 loop that closes 
onto the ligand site upon arsenite-binding, with the specific area outlined by dashed circle. Bottom view is of 
the surface when the molecule on the top was rotated by 90 degrees showing very little effect on that side of 
the molecule. The two molecules were displayed jointly and the surface electrostatic potentials were calculated 
simultaneously in order to ensure the consistency in colouring.
www.nature.com/scientificreports/
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interactions. In summary, at physiological concentrations, AioX, ArxX and ArrX bind the substrate that their 
cognate molybdenum-containing enzyme metabolises.
Discussion
Structure and potential signalling mechanism of AioX. AioX is a class II PBP25 and a member of the 
D-cluster of substrate-binding proteins26. Proteins of this type predominantly bind tetrahedral oxyanions26 and 
while the binding of arsenate and phosphate by ArrX conforms to this trend, the binding of arsenite by AioX 
and ArxX is different as arsenite has a trigonal pyramidal geometric structure. The AioX orthologues are the 
only members of this family that function as signalling proteins. The other members of the family, including the 
structural homologue PhnD, are part of ABC transporters. Other PBPs shown to be involved in signal transduc-
tion include LuxP and TorT, which bind autoinducer-229 and trimethylamine27 and regulate the lux30 and tor28 
operons, respectively. LuxP and TorT however are structurally and phylogenetically distinct to AioX, indicating 
independent evolutionary origins.
The arsenite-bound crystal structure of AioX showed significant conformational changes compared with the 
apo and phosphate-bound structures, specifically in the loop of residues 53–61 and the shape, as well as elec-
trostatic potential, of the protein surface. It is possible that these modifications allow its interaction with the 
sensor histidine kinase, AioS, leading to its activation. The fact that the arsenite-bound and apo-AioX crystals 
displayed differences in molecular packing (forming weak local and crystallographic symmetry related dimers, 
respectively) supports the idea that loop conformation change might result in the generation of a new protein 
interaction surface.
Substrate specificity. Binding experiments performed by ITC showed that AioX and ArxX could only bind 
arsenite from the potential ligands selected, while Arr bound arsenate and phosphate (although the latter with a 
150 times higher Kd). Phosphate concentrations that organisms encounter will depend on the environment. A. 
ehrlichii MLHE-1 is from an environment extremely rich in phosphate (up to 1 mM)31, while gold mine tailings 
often don’t contain enough phosphate to support microbial growth32, and eutrophied lake sediments may contain 
Figure 7. Overlay of the residues forming the ligand binding-sites. (A) Comparison of a phosphate-bound 
AioX (yellow carbon atoms) and the phosphonate-bound PhnD (blue carbon atoms). For clarity, all atoms 
in the phosphonate molecule are coloured blue. All AioX residues involved in phosphate binding are shown 
and labelled. The two AioX-specific hydrogen bonds to the phosphate ion are denoted by dashed lines (2.5 Å 
and 2.6 Å from D210 oxygen and C106 sulphur to phosphate oxygen, respectively). Residues numbered with 
the asterisk refer to the PhnD structure and they are specific for that protein. (B) Comparison of a phosphate-
bound AioX (all yellow) and arsenite-bound AioX (purple carbons). Hydrogen bonds with arsenite are denoted 
by dashed lines while the interactions seen only in the presence of phosphate (same as in 7 A) are shown by 
dotted lines.
Figure 8. Binding-pocket alignment of AioX, ArrX, ArxX and PhnD. Residues that bind phosphate in AioX are 
in bold; residues that bind arsenite in AioX are highlighted in yellow; residues that bind phosphonate in PhnD 
are denoted *; putative signaling loop in AioX is underlined; AioX numbering. Note: there is only one residue 
that binds phosphate but not arsenite, and one residue that binds phosphonate in PhnD that is not conserved in 
AioX/ArrX/ArxX.
www.nature.com/scientificreports/
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7 µM phosphate33 (both Rhizobium sp. str. NT-26 and C. arsenatis were isolated from mining environments). A 
phosphate ion was identified in the crystal structure of AioX, however, its binding does not stabilize the putative 
signalling loop as is the case with arsenite binding. As AioX and ArxX did not bind phosphate in conditions tested 
in ITC, we conclude that AioX and ArxX do not bind phosphate under biologically relevant conditions.
The binding residues involved in arsenite binding in AioX (and presumably ArxX) are also conserved in ArrX, 
which did not bind arsenite but did bind arsenate and phosphate albeit the latter with about 150-fold less affinity. 
Figure 9. Binding thermodynamics of AioX, ArxX and ArrX with their respective substrates. Upper panels: 
raw thermograms; lower panels: integrated binding isotherms. (A) AioX with arsenite; (B) ArxX with arsenite; 
(C) ArrX with arsenate; (D) ArrX with phosphate; (E) Thermodynamic parameters of substrate binding at 
25 °C, values represent mean and standard deviation of three experiments, N: stoichiometry; Kd: dissociation 
constant; ΔH: enthalpy change; ΔS: entropy change.
www.nature.com/scientificreports/
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This finding indicates that binding residues alone do not confer ligand specificity but other factors, such as overall 
conformation of the protein, may play a role in selectivity. The Kd of ArrX for phosphate indicates that in some 
high phosphate environments expression of the arsenate reductase genes may be inhibited.
Evolution of the XSR regulatory cluster. Based on phylogenetic studies, some molybdenum-containing 
enzymes were present in the last universal common ancestor34 and it is hypothesised that Aio is the common 
ancestor to all other members of the DMSO reductase family of molybdoenzymes34,35. Studies have also shown 
that while respiratory molybdoenzymes are principally inherited by vertical gene transfer, they are also subject 
to duplication events and divergence, particularly in the Firmicutes and Proteobacteria phyla36. Such a scenario is 
apparent for divergence of Arx and Arr, where the ‘older’ enzyme Arr, which uses menaquinone to reduce arse-
nate, has diverged to form Arx which uses ubiquinone to oxidise arsenite37.
The congruency of the AioX, AioS and AioR phylogenies to the 16S rRNA gene indicates that the regulatory 
genes emerged early in prokaryotic evolution and their functions adapted to that of the molybdoenzymes, whose 
gene expression they regulate. This is supported by the similar GC content of the regulatory genes and the molyb-
doenzyme genes (data not shown). Adaptation to conform to the function of a cognate molybdoenzyme is also 
observed in the NarJ family of proteins, which function as chaperones and are essential for cofactor insertion in 
several families of molybdoenzymes38.
The aioXSR genes are present in some arsenite oxidisers of the Alpha- and Betaproteobacteria. In Polaromonas 
sp. str. GM1, the Aio is constitutively expressed and a putative phage integrase is present immediately upstream 
of aioB suggesting that this insertion event may have led to the deletion of the aioXSR genes39. We have identified 
other examples of gene loss including in the putative arsenite oxidiser Verminephrobacter aporrectodeae40 where 
a 188 bp fragment of the aioX gene remains, with the rest of the regulatory cluster missing. The putative arsenite 
oxidisers of the genus Burkholderia (member of the Betaproteobacteria) also show how the aioXSR genes may 
have been lost. The aioXSR genes are present in B. cenocepacia but absent in B. vietnamensis, B. multivorans 
and B. ubonensis. Typically, AioA and AioB phylogenies resemble those of the 16S rRNA gene consistent with 
vertical inheritance34,35 which is the case for B. cenocepacia but not the other Burkholderia species. In the other 
Burkholderia species, the AioA subunit clusters with six Pseudomonas (Gammaproteobacteria, which lack aioXSR) 
species. Transposases and integrases are located within 10 kb of the aioBA genes in these Burkholderia species, 
which may indicate loss and horizontal gene transfer of the aioBA genes from Pseudomonas to Burkholderia 
accounting for the absence of aioXSR in those species.
The XSR gene cluster is conserved in all arx-containing organisms but it appears that it has been lost in some 
that contain aio. Phylogenetic analyses of the arrAB genes suggests both vertical and horizontal transfer of these 
genes35 and it’s possible that the regulatory genes were lost after such a horizontal gene transfer event.
In conclusion, we propose that the protein AioX represents a new subfamily of PBPs that bind arsenic 
oxyanions.
Methods
Cloning of aioX and its orthologues. The aioX gene from Rhizobium sp. str. NT-26 and its orthologues, 
arxX from A. ehrlichii str. MLHE-1 and arrX from C. arsenatis were cloned without their signal sequences into 
pPROEX-HTb+ (Invitrogen) for cytoplasmic protein expression in E. coli str. JM109. The aioX and arrX genes 
were amplified from genomic DNA using PCR with the following primers: aioXF, aioXR, arrXF and arrXR 
(Supplementary Table S1) whereas a codon-optimised version of the arxX gene was synthesised (Supplementary 
Fig. S1, GeneArt, ThermoFisher Scientific) and then cloned into pPROEX-HTb+. Expression constructs were 
confirmed by sequencing (GATC Biotech).
Heterologous expression and purification of AioX and its orthologues. AioX, ArxX and ArrX 
were heterologously expressed in 1 l lysogeny broth (LB) (in a 5 l flask) containing 100 µg/ml ampicillin and 40 µM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) at 21 °C with shaking at 180 rpm for 20–24 h. Recombinant pro-
teins were purified from JM109λpir using affinity and size-exclusion chromatography. Cells were harvested by 
centrifugation at 5000 × g for 10 min (4 °C) and the pellets suspended in 40 ml binding buffer (500 mM NaCl, 
20 mM potassium phosphate, 20 mM imidazole, pH 7.3). Cells were centrifuged at 16,000 × g for 10 min (4 °C), 
suspended in 10 ml/gm (wet weight) binding buffer and broken at 14,000 PSI in a pressure cell homogenizer 
(Stansted Fluid Dynamics). Debris and unbroken cells were removed by centrifugation at 30,000 × g for 30 min 
(4 °C). Total cell extract was applied to a 1 ml His Gravitrap (GE Healthcare) Ni-charged column which was then 
washed with 100 ml binding buffer. Bound proteins were eluted from the column in 5 ml elution buffer (500 mM 
NaCl, 20 mM potassium phosphate, 200–500 mM imidazole, pH 7.3). The eluate was filtered through a 0.22 µm 
filter (Millipore), concentrated using a 10,000 MWCO centrifugal filter (Millipore) and loaded onto a Superdex 
75 gel filtration column (GE healthcare) pre-equilibrated with either 20 mM Tricine, pH 7.5 (AioX and ArxX) or 
50 mM Tris-HCl, pH 8 (ArrX). Chromatography was carried out at 0.8 ml/min and fractions corresponding to the 
protein peaks were pooled and concentrated with the 10,000 MWCO centrifugal filter (Millipore), snap frozen in 
liquid nitrogen and stored at −80 °C until required. Protein concentrations were determined with the absorbance 
at 280 nm, measured with a NanoDrop 2000 spectrophotometer (Thermo), and a predicted molar absorbance 
coefficient (ExPASy, Swiss Institute of Biofinformatics)41,42; ε (M−1 cm−1) for AioX, 42860, ArxX 44350, ArrX 
25330. Protein purity was confirmed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis.
For crystallisation, the His-tag was removed from AioX using AcTEV protease (Invitrogen) according to the 
manufacturer’s instruction. The cleaved AioX was then separated from uncleaved protein and the protease using 
affinity chromatography as described above.
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Selenomethionine labelling of the recombinant NT-26 AioX. The sulphur atoms of methionine resi-
dues in AioX were replaced with selenium by providing selenomethionine in the growth medium during protein 
expression using a modified protocol43. JM109 harbouring pPROEX-HTb + -aioX was grown at 37 °C overnight 
in 50 ml of M9 medium44 containing ampicillin (100 μg/ml). The 50 ml was inoculated into 1 l M9 medium and 
incubated at 37 °C with shaking (170 rpm). Cells were grown until OD600 nm ~0.5 followed by the addition of an 
amino acid mix consisting of 100 mg each of lysine, threonine, phenylalanine; 50 mg each of leucine, isoleu-
cine, valine and 60 mg of L-selenomethionine and the cells grown for 15 minutes prior to induction with IPTG. 
The SeMet-AioX protein was purified as described above with one modification, all buffers contained 5 mM of 
dithiothreitol.
Crystallisation of NT-26 AioX, data collection and structure determination. For crystallisation 
of the SeMet-AioX, apo-AioX and AioX-arsenite, the recombinant AioX protein was concentrated to 20 mg/ml. 
Crystallization screening was performed at 16 °C, using a mosquito (TTP Labtech) and the crystallisation screens 
from Hampton Research (Index) and Molecular Dimensions (Structure 1&2, PACT and JCSG). Conditions that 
yielded crystals were as follows: (1) SeMet-AioX crystals grew in 0.49 M NaH2PO4 and 0.91 M K2HPO4 pH 7.2, 
(2) apo-AioX crystals grew in 20% PEG 3350, 0.2 M sodium malonate and 0.1 M Bis-Tris propane, pH 8.5 and, 
(3) AioX-arsenite crystals grew in 25% PEG 3350 and 0.1 M Tris-HCl, pH 7.6. Single crystals were collected and 
mounted in a nylon cryo-loop using 25% glycerol as a cryo-protectant and flash cooled directly in liquid nitrogen 
prior to data collection.
Crystals were screened and X-ray diffraction data collected at the following synchrotron radiation sources: 
Diamond Light Source, beamlines I04 and I02 and Soleil synchrotron, beamline Proxima 1. The diffraction 
images were integrated and scaled using the XDS software package and merged using Aimless in the CCP4 pro-
gram suite45. SAD data were collected from one SeMet-AioX crystal and processed with CCP4 software. The 
MTZ reflection file obtained was used to determine the position of five selenium atoms through SHELX C/D/E 
(CCP4). BUCCANEER was used to generate the AioX model. The final AioX model was generated through 
interactive cycles of model building in Coot46 and a restrained refinement routine in REFMAC547. The structures 
of apo-AioX and arsenite-bound AioX were solved using molecular replacement using the phosphate-bound 
structure as the model, but with the phosphate ion omitted. Phases were obtained with PhaserMR48 and model 
building was performed in Coot46. Refinement of the new structure was carried out in REFMAC547. The data 
collection, processing and refinement statistics are listed in Table 1. All figures of crystal structures and molecular 
surface calculations were prepared using PyMOL49. The following PDB entries were used for structural compar-
isons: 3N5L (a binding protein component of an ABC phosphonate transporter from Pseudomonas aeruginosa) 
and 3P7I (a PhnD in complex with 2-aminoethyl phosphonate from E. coli)50. Three structures and the associated 
structure factors were submitted to PDB with the following IDs: 6ESK, 6EU7 and 6ESV for apo, arsenite-bound 
and a phosphate-bound AioX.
Substrate-binding thermodynamics determined by isothermal titration calorimetry. Binding 
of potential substrates by AioX, ArxX and ArrX was determined by ITC using a MicroCal200 ITC instrument 
(Malvern) at 25 °C with constant stirring of 750 rpm. Binding parameters were calculated using Microcal Origin 
software with a one-site binding model to give estimated values of N, Kd, ΔH, and ΔS. Antimonite (antimonyl 
tatrate; C8H10K2O15Sb2), arsenate (Na2HAsO4), arsenite (NaAsO2), molybdate (Na2MoO4), phosphate (KH2PO4), 
phosphonate (2-aminoethyl phosphonic acid; PO3H2(CH2)2NH2), selenate (Na2SeO4), sulphate (Na2SO4), 
tetrathionate (K2S4O6), thiosulphate (Na2S203) were tested as potential substrates by titrating 1–10 mM substrate 
into 100 µM protein in 1.5–2 µl injections. Protein-substrate combinations that tested positive for binding were 
repeated with three independent protein preparations. AioX and ArxX titrations were performed in 20 mM 
Tricine, pH 7.5 and ArrX in 50 mM Tris-HCl, pH 8. Substrates were prepared in the same buffer as the protein 
into which they were titrated.
Phylogenetic analysis. Sequences from confirmed arsenic metabolisers and other representatives were 
retrieved from GenBank using BLAST51 with NT-26 sequences as queries. Phylogenetic analyses were performed 
using MEGA52. Multiple sequence alignments were generated using MUSCLE53. Phylogenetic trees were con-
structed with the maximum-likelihood method, using the Jones-Taylor-Thornton model, and tested by 200 boot-
strap resamples. Accession numbers used to construct trees are in Supplementary Table S2.
Data availability statement. All data generated or analysed during this study are included in this pub-
lished article (and its Supplementary Information file).
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